Choksi Laboratories Limited (CHOKSILA.BO)
INR 62.99
(-2.64%)
INR 62.99
(-2.64%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 87.1 Million | 82.53 Million | 78.77 Million | 58.98 Million | 28.67 Million | 69.05 Million |
| Net Income | 11.09 Million | 37.21 Million | 3.67 Million | -28.08 Million | -57.14 Million | 22.94 Million |
| Depreciation & Amortization | 57.13 Million | 54.97 Million | 54.27 Million | 46.03 Million | 45.63 Million | 36.78 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 15.98 Million | -31.11 Million | -23.85 Million | -13.35 Million | 25.68 Million | 26.81 Million |
| Other non-cash items | 97 Million | 21.46 Million | 44.68 Million | 54.39 Million | 14.49 Million | -17.49 Million |
| Investing Cash Flow | -68.12 Million | -7.08 Million | -27.08 Million | -76.46 Million | -137.6 Million | -97.6 Million |
| Investments in PPE | -71.34 Million | -41.5 Million | -28.62 Million | -80.97 Million | -140.47 Million | -99.98 Million |
| Acquisitions | 697 Thousand | 32.39 Million | 376 Thousand | 100 Thousand | - | 13 Thousand |
| Investment purchases | - | -61 Thousand | - | - | - | - |
| Sales/Maturities of investments | 1.92 Million | 52 Thousand | - | - | - | - |
| Other Investing Activities | 1.63 Million | 2.03 Million | 1.16 Million | 4.4 Million | 2.86 Million | 2.36 Million |
| Financing Cash Flow | -15.78 Million | -76.14 Million | -50.67 Million | 16.29 Million | 110.92 Million | 21.31 Million |
| Debt repayment | -11.13 Million | -55.12 Million | -41.32 Million | -11.21 Million | -35.43 Million | -42.15 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -34.7 Million | -21.02 Million | -9.34 Million | 27.5 Million | 146.35 Million | 63.46 Million |
| Accounts receivables | 375 Thousand | -7.33 Million | -23.38 Million | -11.71 Million | 18.03 Million | 10.84 Million |
| Accounts payables | 21.31 Million | -22.16 Million | -8.14 Million | -15.93 Million | -7.26 Million | 15.02 Million |
| Inventory | -1.54 Million | 414 Thousand | -1.38 Million | 650 Thousand | 2.28 Million | -1.16 Million |
| Other working capital | -4.15 Million | -2.04 Million | 9.05 Million | 13.64 Million | 12.63 Million | 2.1 Million |
| Cash at beginning of period | 3.37 Million | 4.07 Million | 3.06 Million | 4.25 Million | 2.26 Million | 9.5 Million |
| Cash at end of period | 6.56 Million | 3.37 Million | 4.07 Million | 3.06 Million | 4.25 Million | 2.26 Million |
| Capital Expenditure | -71.34 Million | -41.5 Million | -28.62 Million | -80.97 Million | -140.47 Million | -99.98 Million |
| Effect of forex changes on cash | - | -1000.00 | - | - | - | 82.41 Thousand |
| Net cash flow / Change in cash | 3.19 Million | -696 Thousand | 1.01 Million | -1.19 Million | 1.99 Million | -7.23 Million |
| Free Cash Flow | 15.75 Million | 41.03 Million | 50.14 Million | -21.98 Million | -111.8 Million | -30.93 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 11.09 Million | 624 Thousand | 68 Thousand | 3.57 Million | 37.21 Million | 29.86 Million |
| Depreciation & Amortization | 57.13 Million | 14.26 Million | 14.08 Million | 13.87 Million | 54.97 Million | 14.24 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 15.98 Million | - | - | - | -31.11 Million | - |
| Other non-cash items | 97 Million | -14.26 Million | -14.08 Million | -13.87 Million | 21.46 Million | -14.24 Million |
| Investing Cash Flow | -68.12 Million | - | - | - | -7.08 Million | - |
| Investments in PPE | -71.34 Million | - | - | - | -41.5 Million | - |
| Acquisitions | 697 Thousand | - | - | - | 32.39 Million | - |
| Investment purchases | - | - | - | - | -61 Thousand | - |
| Sales/Maturities of investments | 1.92 Million | - | - | - | 52 Thousand | - |
| Other Investing Activities | - | - | - | - | 2.03 Million | - |
| Financing Cash Flow | -15.78 Million | - | - | - | -76.14 Million | - |
| Debt repayment | -11.13 Million | - | - | - | -55.12 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | -21.02 Million | - |
| Accounts receivables | 375 Thousand | - | - | - | -7.33 Million | - |
| Accounts payables | 21.31 Million | - | - | - | -22.16 Million | - |
| Inventory | -1.54 Million | - | - | - | 414 Thousand | - |
| Other working capital | -4.15 Million | - | - | - | -2.04 Million | - |
| Cash at beginning of period | 3.37 Million | 92.56 Million | 92.49 Million | 3.37 Million | 4.07 Million | -26.48 Million |
| Cash at end of period | 6.56 Million | 624 Thousand | 92.56 Million | 3.57 Million | 3.37 Million | 3.37 Million |
| Capital Expenditure | -71.34 Million | - | - | - | -41.5 Million | - |
| Effect of forex changes on cash | - | - | - | - | -1000.00 | - |
| Net cash flow / Change in cash | 3.19 Million | -91.94 Million | 68 Thousand | 204 Thousand | -696 Thousand | 29.86 Million |
| Free Cash Flow | 15.75 Million | 624 Thousand | 68 Thousand | 3.57 Million | 41.03 Million | 29.86 Million |
CWPE
ODV
VLSFINANCE
GGC
ORIENTPPR
MMY